Evidence map›Paper›PMID 31577861›Full record

SynthesisInternational journal of cancer2020

Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk.

Juncheng Dai, Mingtao Huang, Christopher I Amos, Rayjean J Hung, Adonina Tardon, Angeline Andrew, Chu Chen, David C Christiani, Demetrius Albanes, Gadi Rennert and 29 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in International journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 14 countries.

Juncheng DaiDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.ORCID 0000-0002-3909-5671
Mingtao HuangDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Christopher I AmosDepartment of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, Houston, TX.
Rayjean J HungEpidemiology Division, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Adonina TardonFaculty of Medicine, University of Oviedo and CIBERESP, Oviedo, Spain.
Angeline AndrewDepartment of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, NH.ORCID 0000-0002-3731-5300
Chu ChenDepartment of Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0003-2267-8050
David C ChristianiDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Gadi RennertTechnion Faculty of Medicine, Carmel Medical Center, Israel Institute of Technology, Haifa, Israel.
Jingyi FanDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Gary GoodmanPublic Health Sciences Division, Swedish Cancer Institute, Seattle, WA.
Geoffrey LiuEpidemiology Division, Princess Margaret Cancer Center, Toronto, ON, Canada.
John K FieldRoy Castle Lung Cancer Research Programme, Department of Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Kjell GrankvistUnit of Clinical Chemistry, Department of Medical Biosciences, Umeå University, Umeå, Sweden.
Lambertus A KiemeneyDepartment of Health Evidence, Radboud University Medical Center, Nijmegen, Germany.
Loic Le MarchandDepartment of Epidemiology, University of Hawaii Cancer Center, Honolulu, HI.
Matthew B SchabathDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Mattias JohanssonGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Melinda C AldrichDepartment of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN.
Mikael JohanssonDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
Neil CaporasoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Philip LazarusWashington State University College of Pharmacy, Spokane, WA.
Stephan LamDepartment of Integrative Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Stig E BojesenDepartment of Clinical Biochemistry, Copenhagen University Hospital, Copenhagen, Denmark.ORCID 0000-0002-4061-4133
Susanne ArnoldMarkey Cancer Center, University of Kentucky, Lexington, KY.
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Angela RischCancer Center Cluster Salzburg at PLUS, Department of Molecular Biology, University of Salzburg, Heidelberg, Austria.
H-Erich WichmannInstitute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig Maximilians University, Munich, Bavaria, Germany.
Heike BickebollerDepartment of Genetic Epidemiology, University Medical Center Goettingen, Goettingen, Germany.
Paul BrennanGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Sanjay SheteDepartment of Epidemiology, University of Texas, MD Anderson Cancer Center, Houston, TX.
Olle MelanderDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Hans BrunnstromDepartment of Clinical Sciences, Lund University, Lund, Sweden.
Shan ZienolddinyNational Institute of Occupational Health (STAMI), Oslo, Norway.
Penella WollAcademic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK.
Victoria StevensEpidemiology Research Program, American Cancer Society, Atlanta, GA.
Zhibin HuDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.ORCID 0000-0001-6878-9464
Hongbing ShenDepartment of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.ORCID 0000-0002-2581-5906
Centre international de recherche sur le cancer · FRJiangsu Cancer Hospital · CNNational Cancer Institute · USLund University · SENanjing Medical University · CNAmerican Cancer Society · USBC Cancer Agency · CACape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZADartmouth–Hitchcock Medical Center · USHarvard University · USLunenfeld-Tanenbaum Research Institute · CAMoffitt Cancer Center · USNational Institute of Occupational Health · NONephrologisches Zentrum Goettingen · DEPrincess Margaret Cancer Centre · CARadboud University Nijmegen · NLSwedish Medical Center · USTechnion – Israel Institute of Technology · ILTexas Medical Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Translating Molecular and Clinical Data to Population Lung Cancer Risk AssessmentU19CA203654 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Christopher I. Amos · 2017 to 2026
$23.7M
The Boston Lung Cancer Survival CohortU01CA209414 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI David C Christiani · 2017 to 2026
$12.2M
SPORE in Lung CancerP50CA119997 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GABRILOVICH, DMITRY I · 2008 to 2012
$11.0M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
Infrastructure Support and Pilot Tissue Collection for the CARET BiorepositoryU01CA167462 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEUHOUSER, MARIAN L · 2018 to 2022
$2.9M
NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA076292NCI NIH HHS P50 CA119997NCI NIH HHS R01 CA092824NCI NIH HHS R35 CA197449NCI NIH HHS U01 CA167462NCI NIH HHS U01 CA209414NCI NIH HHS U19 CA148127NCI NIH HHS U19 CA203654World Health Organization 001
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have identified 45 susceptibility loci associated with lung cancer. Only less than SNPs, small insertions and deletions (INDELs) are the second most abundant genetic polymorphisms in the human genome. INDELs are highly associated with multiple human diseases, including lung cancer. However, limited studies with large-scale samples have been available to systematically evaluate the effects of INDELs on lung cancer risk. Here, we performed a large-scale meta-analysis to evaluate INDELs and their risk for lung cancer in 23,202 cases and 19,048 controls. Functional annotations were performed to further explore the potential function of lung cancer risk INDELs. Conditional analysis was used to clarify the relationship between INDELs and SNPs. Four new risk loci were identified in genome-wide INDEL analysis (1p13.2: rs5777156, Insertion, OR = 0.92, p = 9.10 × 10

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyHumansINDEL MutationLung Neoplasmsgenome-wide association studiesINDELslung cancer

Identifiers

PMID31577861
PMCPMC7101262
OpenAlexW2977245743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.